HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
This event, organized by France BioLead and placed under the patronage of French President Emmanuel Macron, aims to highlight a strategic sector at the heart of healthcare and innovation.
We have always been committed to developing innovative biotechnology solutions, and every day we contribute to advancing biomanufacturing in France and internationally.
Our commitment is to promote biomanufacturing in France and worldwide.
Find below the official JNBB 2025 press release:
We’re pleased to share our second CSR report, highlighting the actions and commitments we carried out throughout 2024.
A Global Scientific Gathering Dedicated to Hyaluronic Acid Innovation.
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.